Execution of an investment agreement and contribution in kind of a controlling stake by Pléiade Investissement to New Gen Holding, leading to a proposed public tender offer [...]
May 25 2022 - 12:01PM
Execution of an investment agreement and contribution in kind of a
controlling stake by Pléiade Investissement to New Gen Holding,
leading to a proposed public tender offer [...]
Execution of an investment
agreement and contribution
in kind of a controlling
stake by Pléiade
Investissement to New Gen Holding, leading
to a proposed public tender offer, and, if
applicable, a squeeze-out, by New Gen Holding on
Generix Group (GENX - FR0010501692) shares.
Paris, May
25, 2022 – Following
their entry into exclusive negotiations announced through a
previous press release dated April 22, 2022, Generix Group, its top
management, including Mr. Jean-Charles Deconninck, Mrs. Aïda
Collette-Sène, Mr Ludovic Luzza and Mr Philippe Seguin (the
"Managers") and Pléiade Investissement and its
management ("Pléiade") announce having obtained
the approval of the employee representative bodies and having
entered into a binding investment agreement
(the "Agreement") with Montefiore Investment
("Montefiore") on May 24, 2022, which provides for
the acquisition by a special purpose company, New Gen Holding, of
the shares held by the Managers and Pléiade in Generix Group, by
way of contributions in kind and sales of shares (the
"Transaction"), and the filing of a tender offer
funded by Montefiore (the "Tender Offer").
In the context of the Transaction, pursuant to
the provisions of the Agreement, Pléiade Investissement transferred
a controlling stake of 42.40% of the share capital of Generix Group
(35.48% on a fully diluted basis), representing its entire
shareholding in Generix Group to New Gen Holding.
The completion of the Transaction, which remains
subject to the approval of the French Competition Authority, could
take place during June, and will lead to the filing of the Tender
Offer.
The parties will keep the market informed of the
completion of these different steps.
- EXT-EN-Investment protocol signing_Generix Group_final
Generix (LSE:0JAW)
Historical Stock Chart
From May 2024 to Jun 2024
Generix (LSE:0JAW)
Historical Stock Chart
From Jun 2023 to Jun 2024